The Food and Drug Administration on Thursday approved its first-ever cancer vaccine, ushering in a new era of cancer treatments.
Named Provenge, the drug targets prostate cancer; in clinical trials, it extended the lives of patients about four months compared with a placebo.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.
Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email
Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email
Copyright © 2012 Popular Science
A Bonnier Corporation Company. All rights reserved. Reproduction in whole or in part without permission is prohibited.